RSS

biotech

Biotech company owned by PPF Group, Sotio, has announced the completion of its acquisition of Cytune Pharma. more

News

Vienna-based biotech company, PhagoMed Biopharma, has received more than €4 million in grants and private investments, which will be used to boost the development of alternative therapies to combat antibiotic-resistant bacteria. more

News

Clinical-stage biopharmaceutical company, Immatics Biotechnologies, has entered into a research collaboration and licence agreement with international biotech company, Genmab, to develop next generation bispecific cancer immunotherapies. more

News

Aptamer Group — a biotech business — has closed its Series A financing round, securing $2.2 million from overseas investors to support its aptamer development programme. more

News

Affordable biolab spaces are now available at the Old Laundry Yard in Shepherd’s Bush Market thanks to a partnership between Open Cell, U+I and the London Borough of Hammersmith and Fulham and SynbiCITE. more

News

The Industrial Biotechnology Leadership Forum (IBLF) has launched a new National Industrial Biotechnology Strategy to 2030, which will be promoted in partnership with the UK BioIndustry Association (BIA). more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

UK-based biotech, Orbit Discovery, has closed its series A financing round, raising £6.9 million, which will enable the company to expand its platform and achieve milestones in current partnerships. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The UK BioIndustry Association (BIA) has called on the government to create a new venture capital fund structure so that the public will be able to invest in biotech. more

News

With a spring in their step, manufacturing experts from pharma and biotech descend on New York to enjoy the offerings from this year’s Interphex meeting. Here’s our brief round-up of what to see from exhibitors at the event on day one… more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

The BIA and business intelligence group, Informa, have released their first quarterly financing update on the biotech sector, showing that venture capital financing and follow on financings on the public markets are off to a solid start more

Analysis

As Analytica 2018 kicks off in Messe München, we take a brief sneak peek at a few of the exciting developments being offered on the show floor at this vast event for lab tech, analysis and biotech. more

Technology

With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders more

Opinion

Clinical-stage biotech company, Genoscience Pharma, has started administering GNS561 in a Phase I/IIa trial of patients with advanced liver cancer. more

News

A Phase II clinical trial has begun in the US to evaluate a new drug, GDC-0084, that targets the signalling pathway implicated in almost all (90%) of glioblastoma multiforme brain cancer cases. more

News

As the guidelines for the negotiations of future relations between the EU and the UK are approved, allowing the progression of Brexit talks, pharma, biotech and manufacturing industry leaders give their opinions on the transition. more

Opinion

A financing round worth €38 million has been completed by biotech company, NMD Pharma, to advance the treatments of neuromuscular disorders. more

News

The associations representing the UK’s pharma and biotech industries have announced their support of the recently published findings of the new Health and Social Care Committee report into Brexit. more

News